Clinical Trial Update: A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies

View source ↗

Summary

This clinical trial update reports the withdrawal of a study evaluating erythropoietin receptor agonists in anemia patients who developed anti-erythropoietin an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• erythropoietin receptor agonists

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia | Status: WITHDRAWN